FHC, Inc. Announces Official Partnership with Avrio MedTech to Distribute Halyzia® SEEG Review Software
Bowdoin, ME – March 26, 2026 – FHC, Inc., a global leader in neuroscience instrumentation and electrophysiology solutions, today announced an official partnership with Avrio MedTech to distribute Halyzia®, Avrio’s advanced SEEG review and analysis software. This collaboration strengthens FHC’s commitment to empowering researchers with the most intuitive, high‑performance tools for neuroscience and epilepsy research.
For more than 50 years, FHC and its partner brands have supported the world’s most demanding neuroscience applications by delivering high‑precision electrophysiology recording systems, neurophysiology tools, and experiment‑control technologies. This new partnership extends that mission by adding a state‑of‑the‑art software designed to accelerate SEEG interpretation and enhance clinical insights.
“Integrating Halyzia® into our portfolio represents a significant milestone in our commitment to innovation,” said Cosmin Serban, CEO, FHC, Inc. “Our customers rely on FHC not only for world‑class hardware, but also for powerful, modern analytical software. Halyzia® delivers exactly that, an intuitive, scalable software that elevates the way researchers interact with SEEG data.”
A Smarter, More Intuitive Way to Review SEEG Signals
Developed by Avrio MedTech, Halyzia® is a next‑generation SEEG review environment designed to streamline quantitative analysis workflows. Currently applied to research Halyzia®’s ultimate goal is to accelerate high‑stakes decision‑making in epilepsy monitoring and surgical planning.
Halyzia® provides users with a clean, modern interface designed to:
- Review macro‑ and micro‑electrode signals concurrently, offering simultaneous insights into neuronal action potentials and local field potentials
- Detect and quantify interictal biomarkers of epilepsy using advanced signal‑processing tools
- Analyze seizure onset patterns
- Improve data quality assessment with built‑in tools for evaluating signal integrity
- Integrate seamlessly with NeuraLynx Pegasus platform, expanding the capabilities of existing electrophysiology solutions
“Our collaboration with FHC allows us to bring Halyzia® to more researchers around the world,” said Karine Seymour, CEO & Co-Founder, Avrio MedTech “FHC’s decades‑long legacy in neuroscience, combined with their trusted customer relationships, makes them the ideal partner as we expand access to advanced SEEG review technologies.”
Driving the Future of Epilepsy Research and Neurosurgical Planning
As epilepsy centers and neuroscience labs face growing data volumes and increasingly complex diagnostic demands, intuitive software solutions like Halyzia® play a vital role in improving accuracy, efficiency, and patient outcomes. Together, FHC and Avrio MedTech aim to accelerate innovation across the entire SEEG workflow, from data acquisition to advanced computational analysis.
Availability
Halyzia® is now available through FHC’s global sales channels. Customers can learn more or request a demonstration by visiting www.avriomedtech.com or contacting their FHC representative.
___________________________________________________________________________________
About FHC, Inc.
FHC, Inc. has been advancing neuroscience for over five decades by delivering precision instrumentation, neurosurgical tools, electrophysiology systems, and integrated software solutions. FHC supports clinical and research communities around the world with products that enable breakthroughs in neuromodulation, neurophysiology, epilepsy research, and functional neurosurgery.
About Avrio MedTech
Avrio MedTech is a startup company, spin-off of the Brain and Cognition Research Center in Toulouse, France. They valorize 10 years of academic research in signal processing, quantitative analysis on SEEG signals, complex data visualization, and computer science. Avrio MedTech’s solution, Halyzia®, is a modern, intuitive software enhancing SEEG data review through advanced visualization, streamlined navigation, and automated signal analysis capabilities.